Classes
DEA Class; Rx
Common Brand Names; Restoril
- Sedative/Hypnotics
Description
Oral benzodiazepine; shorter half-life than flurazepam and no active metabolites; for insomnia.
Indications
Indicated for the short-term treatment of insomnia.
Contraindications
Documented hypersensitivity
Acute alcohol intoxication
Narrow-angle glaucoma (questionable)
Adverse Effects
- Drowsiness (9.1%)
- Dizziness (4.5%)
- Lethargy (4.5%)
- Hangover (2.5%)
- Diarrhea (1.7%)
- Euphoria (1.5%)
- Weakness (1.4%)
- Confusion (1.3%)
- Vertigo (1.2%)
- Amnesia
- Angioedema
- Blood dyscrasias
- Sleep-related behavior (eg, sleep driving, sleep cooking, sleep eating)
- Ataxia
Warnings
Use caution in COPD, sleep apnea, renal/hepatic disease, impaired gag reflex, open-angle glaucoma (questionable), alcoholism, respiratory disease, depression, suicidal ideation
May impair ability to perform hazardous tasks
Caution with IV use in shock, coma, and depressed respiration and in patients who recently received other respiratory depressants
Anterograde amnesia may occur
Use caution in patients with history of drug abuse or acute alcoholism; tolerance, psychological and physical dependence may occur with prolonged use
Use in myasthenia gravis is allowed in limited circumstances
Use caution in severe respiratory depression and depressed neuroses, psychotic reactions
Paradoxical hyperactive aggressive behavior reported
Therapy can cause drowsiness and a decreased level of consciousness; patients, particularly the elderly, are at higher risk of falls
May cause hyperactive or aggressive behavior
Use of drug, particularly in patients at elevated risk of abuse, necessitates counseling about risks and proper use of drug along with monitoring for signs and symptoms of abuse, misuse, and addiction; do not exceed recommended dosing frequency
Avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (eg, opioid analgesics, stimulants); advise patients on proper disposal of unused drug; if a substance use disorder is suspected, evaluate patient and institute (or refer them for) early treatment, as appropriate
Pregnancy and Lactation
Pregnancy Category: X
Lactation: Avoid if breastfeeding
Maximum Dosage
30 mg/day PO.
30 mg/day PO.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Temazepam
capsule: Schedule IV
- 7.5mg
- 15mg
- 22.5mg
- 30mg